- Home
- LNSR vs INCR Comparison
LNSR vs INCR Comparison
Compare LNSR & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNSR
- INCR
- Stock Information
- Founded
- LNSR 2004
- INCR 1994
- Country
- LNSR United States
- INCR Israel
- Employees
- LNSR N/A
- INCR N/A
- Industry
- LNSR Medical Electronics
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- LNSR Health Care
- INCR Health Care
- Exchange
- LNSR Nasdaq
- INCR Nasdaq
- Market Cap
- LNSR 63.4M
- INCR 65.3M
- IPO Year
- LNSR N/A
- INCR N/A
- Fundamental
- Price
- LNSR $7.57
- INCR $1.46
- Analyst Decision
- LNSR
- INCR
- Analyst Count
- LNSR 0
- INCR 0
- Target Price
- LNSR N/A
- INCR N/A
- AVG Volume (30 Days)
- LNSR 45.1K
- INCR 29.1K
- Earning Date
- LNSR 11-07-2024
- INCR 12-31-2024
- Dividend Yield
- LNSR N/A
- INCR N/A
- EPS Growth
- LNSR N/A
- INCR N/A
- EPS
- LNSR N/A
- INCR N/A
- Revenue
- LNSR $48,868,000.00
- INCR $72,420,918.00
- Revenue This Year
- LNSR $25.07
- INCR N/A
- Revenue Next Year
- LNSR $24.95
- INCR $39.30
- P/E Ratio
- LNSR N/A
- INCR N/A
- Revenue Growth
- LNSR 21.29
- INCR N/A
- 52 Week Low
- LNSR $2.45
- INCR $1.17
- 52 Week High
- LNSR $8.17
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- LNSR 55.35
- INCR 52.10
- Support Level
- LNSR $7.13
- INCR $1.30
- Resistance Level
- LNSR $7.98
- INCR $1.47
- Average True Range (ATR)
- LNSR 0.49
- INCR 0.05
- MACD
- LNSR -0.07
- INCR 0.02
- Stochastic Oscillator
- LNSR 48.89
- INCR 88.83
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.